Gerald B. Pier

Oprichter bij ALOPEXX, INC.

74 jaar

Consumer Services

Health Technology

Profiel

Gerald B. Pier is the founder of Alopexx, Inc., founded in 2006.
Dr. Pier holds the title of Director & Chief Scientific Officer at Alopexx, Inc. Dr. Pier is also the founder of Alopexx Enterprises LLC..
Dr. Pier currently works at Harvard Medical School as a Professor.
Dr. Pier earned a doctorate from the University of California, Berkeley and completed undergraduate studies at the University of the Pacific.

Actieve functies van Gerald B. Pier

Bedrijven	Functie	Begin
ALOPEXX, INC.	Oprichter	01-01-2006
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Alopexx Enterprises LLC Alopexx Enterprises LLC BiotechnologyHealth Technology Engages in investing and managing health care companies	Oprichter	-

Alle actieve functies van Gerald B. Pier

Opleiding van Gerald B. Pier

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Gerald B. Pier in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	5
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of the Pacific University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alopexx Enterprises LLC Alopexx Enterprises LLC BiotechnologyHealth Technology Engages in investing and managing health care companies	Health Technology
Alopexx, Inc. Alopexx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops novel and broad-spectrum immune-mediated therapeutics	Health Technology